IL15 and Sepsis: Recent studies imply that some novel immunomodulatory agents, including IL-7, IL-15, GM-CSF, IFN-γ, and co-inhibitory molecule blockade can reduce the clinical morbidity associated with severe sepsis and septic shock [8,9,10].